Larijani B

References (18)

Title : New benzimidazole-indole-amide derivatives as potent alpha-glucosidase and acetylcholinesterase inhibitors - Naimi_2025_Arch.Pharm.(Weinheim)_358_e2400354
Author(s) : Naimi N , Karimian S , Dastyafteh N , Noori M , Mohammadi-Khanaposhtani M , Dadgar A , Larijani B , Lotfi V , Celik I , Aktas A , Sadeghian N , Taslimi P , Mahdavi M
Ref : Arch Pharm (Weinheim) , 358 :e2400354 , 2025
Abstract :
PubMedSearch : Naimi_2025_Arch.Pharm.(Weinheim)_358_e2400354
PubMedID: 39721987

Title : Isoindolinedione-Benzamide Pyridinium Derivatives for Targeting Alzheimer's Disease - Noori_2024_ACS.Omega_9_48032
Author(s) : Noori M , Khalili Ghomi M , Dastyafteh N , Oliyaei N , Hamedifar H , Javanshir S , Tanideh N , Sattarinezhad E , Sattari F , Haghani M , Rahmani H , Larijani B , Mahdavi M , Hajimiri MH , Iraji A
Ref : ACS Omega , 9 :48032 , 2024
Abstract :
PubMedSearch : Noori_2024_ACS.Omega_9_48032
PubMedID: 39676969

Title : Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3beta level targeting Alzheimer's disease - Noori_2023_Int.J.Biol.Macromol__127392
Author(s) : Noori M , Dastyafteh N , Safapoor S , Ghomi MK , Tanideh R , Zomorian K , Hamedifar H , Dara M , Zare S , Irajie C , Javanshir S , Rastegar H , Panahi N , Larijani B , Mahdavi M , Hajimiri MH , Iraji A
Ref : Int J Biol Macromol , :127392 , 2023
Abstract :
PubMedSearch : Noori_2023_Int.J.Biol.Macromol__127392
PubMedID: 37827412

Title : Dual functional cholinesterase and carbonic anhydrase inhibitors for the treatment of Alzheimer's disease: Design, synthesis, in vitro, and in silico evaluations of coumarin-dihydropyridine derivatives - Zahedi_2023_J.Mol.Struct_1276_134767
Author(s) : Zahedi NA , Mohammadi-Khanaposhtani M , Rezaei P , Askarzadeh M , Alikhani M , Adib M , Mahdavi M , Larijani B , Niakan S , Tehrani MB , Taslimi P , Gulcin I
Ref : J Mol Struct , 1276 :134767 , 2023
Abstract :
PubMedSearch : Zahedi_2023_J.Mol.Struct_1276_134767
PubMedID:

Title : Recent developments in the design and synthesis of benzylpyridinium salts: Mimicking donepezil hydrochloride in the treatment of Alzheimer's disease - Sepehri_2022_Front.Chem_10_936240
Author(s) : Sepehri S , Saeedi M , Larijani B , Mahdavi M
Ref : Front Chem , 10 :936240 , 2022
Abstract :
PubMedSearch : Sepehri_2022_Front.Chem_10_936240
PubMedID: 36226120

Title : New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and alpha-glucosidase enzymes - Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
Author(s) : Mohammadi-Khanaposhtani M , Nori M , Valizadeh Y , Javanshir S , Dastyafteh N , Moaazam A , Hosseini S , Larijani B , Adibi H , Biglar M , Hamedifar H , Mahdavi M , Kamci H , Karakus A , Taslimi P
Ref : Arch Pharm (Weinheim) , :e2100313 , 2022
Abstract :
PubMedSearch : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
PubMedID: 35132681

Title : New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies - Mirzazadeh_2021_Arch.Pharm.(Weinheim)__e2000471
Author(s) : Mirzazadeh R , Asgari MS , Barzegari E , Pedrood K , Mohammadi-Khanaposhtani M , Sherafati M , Larijani B , Rastegar H , Rahmani H , Mahdavi M , Taslimi P , Uc EM , Gulcin I
Ref : Arch Pharm (Weinheim) , :e2000471 , 2021
Abstract :
PubMedSearch : Mirzazadeh_2021_Arch.Pharm.(Weinheim)__e2000471
PubMedID: 33999440

Title : Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives - Pedrood_2021_Int.J.Biol.Macromol_170_1
Author(s) : Pedrood K , Sherafati M , Mohammadi-Khanaposhtani M , Asgari MS , Hosseini S , Rastegar H , Larijani B , Mahdavi M , Taslimi P , Erden Y , Gunay S , Gulcin I
Ref : Int J Biol Macromol , 170 :1 , 2021
Abstract :
PubMedSearch : Pedrood_2021_Int.J.Biol.Macromol_170_1
PubMedID: 33352155

Title : Synthesis, characterization, molecular docking, and biological activities of coumarin-1,2,3-triazole-acetamide hybrid derivatives - Sepehri_2020_Arch.Pharm.(Weinheim)__e2000109
Author(s) : Sepehri N , Mohammadi-Khanaposhtani M , Asemanipoor N , Hosseini S , Biglar M , Larijani B , Mahdavi M , Hamedifar H , Taslimi P , Sadeghian N , Gulcin I
Ref : Arch Pharm (Weinheim) , :e2000109 , 2020
Abstract :
PubMedSearch : Sepehri_2020_Arch.Pharm.(Weinheim)__e2000109
PubMedID: 32643792

Title : Novel quinazolin-sulfonamid derivatives: synthesis, characterization, biological evaluation, and molecular docking studies - Sepehri_2020_J.Biomol.Struct.Dyn__1
Author(s) : Sepehri N , Mohammadi-Khanaposhtani M , Asemanipoor N , Hosseini S , Biglar M , Larijani B , Mahdavi M , Hamedifar H , Taslimi P , Sadeghian N , Norizadehtazehkand M , Gulcin I
Ref : J Biomol Struct Dyn , :1 , 2020
Abstract :
PubMedSearch : Sepehri_2020_J.Biomol.Struct.Dyn__1
PubMedID: 33222620

Title : N-Cyclohexylimidazo[1,2-a]pyridine derivatives as multi-target-directed ligands for treatment of Alzheimer's disease - Haghighijoo_2020_Bioorg.Chem_103_104146
Author(s) : Haghighijoo Z , Akrami S , Saeedi M , Zonouzi A , Iraji A , Larijani B , Fakherzadeh H , Sharifi F , Arzaghi SM , Mahdavi M , Edraki N
Ref : Bioorg Chem , 103 :104146 , 2020
Abstract :
PubMedSearch : Haghighijoo_2020_Bioorg.Chem_103_104146
PubMedID: 32777579

Title : Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents - Tehrani_2019_Chem.Biodivers_16_e1900144
Author(s) : Tehrani MB , Rezaei Z , Asadi M , Behnammanesh H , Nadri H , Afsharirad F , Moradi A , Larijani B , Mohammadi-Khanaposhtani M , Mahdavi M
Ref : Chem Biodivers , 16 :e1900144 , 2019
Abstract :
PubMedSearch : Tehrani_2019_Chem.Biodivers_16_e1900144
PubMedID: 31155827

Title : Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease - Asadi_2019_Chem.Biodivers_16_e1900370
Author(s) : Asadi M , Ebrahimi M , Mohammadi-Khanaposhtani M , Azizian H , Sepehri S , Nadri H , Biglar M , Amanlou M , Larijani B , Mirzazadeh R , Edraki N , Mahdavi M
Ref : Chem Biodivers , 16 :e1900370 , 2019
Abstract :
PubMedSearch : Asadi_2019_Chem.Biodivers_16_e1900370
PubMedID: 31523926

Title : Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents - Mahdavi_2019_Chem.Biodivers_16_e1800488
Author(s) : Mahdavi M , Hariri R , Mirfazli SS , Lotfian H , Rastergari A , Firuzi O , Edraki N , Larijani B , Akbarzadeh T , Saeedi M
Ref : Chem Biodivers , 16 :e1800488 , 2019
Abstract :
PubMedSearch : Mahdavi_2019_Chem.Biodivers_16_e1800488
PubMedID: 30720917

Title : Design, synthesis, and biological evaluation of novel 4-oxobenzo[d]1,2,3-triazin-benzylpyridinum derivatives as potent anti-Alzheimer agents - Hosseini_2019_Bioorg.Med.Chem_27_2914
Author(s) : Hosseini F , Ramazani A , Mohammadi-Khanaposhtani M , Barazandeh Tehrani M , Nadri H , Larijani B , Mahdavi M
Ref : Bioorganic & Medicinal Chemistry , 27 :2914 , 2019
Abstract :
PubMedSearch : Hosseini_2019_Bioorg.Med.Chem_27_2914
PubMedID: 31128990

Title : New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study - Mollazadeh_2019_Bioorg.Chem_87_506
Author(s) : Mollazadeh M , Mohammadi-Khanaposhtani M , Zonouzi A , Nadri H , Najafi Z , Larijani B , Mahdavi M
Ref : Bioorg Chem , 87 :506 , 2019
Abstract :
PubMedSearch : Mollazadeh_2019_Bioorg.Chem_87_506
PubMedID: 30928873

Title : Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives - Rastegari_2018_Bioorg.Chem_83_391
Author(s) : Rastegari A , Nadri H , Mahdavi M , Moradi A , Mirfazli SS , Edraki N , Moghadam FH , Larijani B , Akbarzadeh T , Saeedi M
Ref : Bioorg Chem , 83 :391 , 2018
Abstract :
PubMedSearch : Rastegari_2018_Bioorg.Chem_83_391
PubMedID: 30412794

Title : Novel cinnamic acid-tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study - Ghafary_2018_Arch.Pharm.(Weinheim)_351_e1800115
Author(s) : Ghafary S , Najafi Z , Mohammadi-Khanaposhtani M , Nadri H , Edraki N , Ayashi N , Larijani B , Amini M , Mahdavi M
Ref : Arch Pharm (Weinheim) , 351 :e1800115 , 2018
Abstract :
PubMedSearch : Ghafary_2018_Arch.Pharm.(Weinheim)_351_e1800115
PubMedID: 30284339